{"id":"https://openalex.org/W4394914166","doi":"https://doi.org/10.3390/antib13020031","title":"Fc\u03b3-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy","display_name":"Fc\u03b3-Receptor-Independent Controlled Activation of CD40 Canonical Signaling by Novel Therapeutic Antibodies for Cancer Therapy","publication_year":2024,"publication_date":"2024-04-18","ids":{"openalex":"https://openalex.org/W4394914166","doi":"https://doi.org/10.3390/antib13020031","pmid":"https://pubmed.ncbi.nlm.nih.gov/38651411","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11036229"},"language":"en","primary_location":{"id":"doi:10.3390/antib13020031","doi":"https://doi.org/10.3390/antib13020031","is_oa":true,"landing_page_url":"https://doi.org/10.3390/antib13020031","pdf_url":"https://www.mdpi.com/2073-4468/13/2/31/pdf?version=1713447617","source":{"id":"https://openalex.org/S2739070576","display_name":"Antibodies","issn_l":"2073-4468","issn":["2073-4468"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antibodies","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2073-4468/13/2/31/pdf?version=1713447617","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083442615","display_name":"Karsten Beckmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134778","display_name":"BioNTech (Germany)","ror":"https://ror.org/04fbd2g40","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210134778"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Karsten Beckmann","raw_affiliation_strings":["Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany",", . - , , of , , "],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany","institution_ids":["https://openalex.org/I4210134778"]},{"raw_affiliation_string":", . - , , of , , ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005395885","display_name":"Carmen Reitinger","orcid":"https://orcid.org/0000-0003-0515-5119","observed_orcids":["https://orcid.org/0000-0003-0515-5119"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Carmen Reitinger","raw_affiliation_strings":["Division of Genetics, Department of Biology, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, 91058 Erlangen, Germany",", . - , , of , , "],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Genetics, Department of Biology, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, 91058 Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]},{"raw_affiliation_string":", . - , , of , , ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100658568","display_name":"Xianglei Yan","orcid":"https://orcid.org/0000-0003-4783-0004","observed_orcids":["https://orcid.org/0000-0003-4783-0004"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Xianglei Yan","raw_affiliation_strings":["Center of Molecular Medicine, 171 76, Stockholm, Sweden","Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Visionsgatan 4, BioClinicum J7:30, 171 64, Stockholm, Sweden",", . - , , of , , "],"raw_orcid":"https://orcid.org/0000-0003-4783-0004","affiliations":[{"raw_affiliation_string":"Center of Molecular Medicine, 171 76, Stockholm, Sweden","institution_ids":[]},{"raw_affiliation_string":"Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Visionsgatan 4, BioClinicum J7:30, 171 64, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]},{"raw_affiliation_string":", . - , , of , , ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067529180","display_name":"Anna Carle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134778","display_name":"BioNTech (Germany)","ror":"https://ror.org/04fbd2g40","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210134778"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Anna Carle","raw_affiliation_strings":["Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany",", . - , , of , , "],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany","institution_ids":["https://openalex.org/I4210134778"]},{"raw_affiliation_string":", . - , , of , , ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092552150","display_name":"Eva Bl\u00fcmle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134778","display_name":"BioNTech (Germany)","ror":"https://ror.org/04fbd2g40","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210134778"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Eva Bl\u00fcmle","raw_affiliation_strings":["Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany",", . - , , of , , "],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany","institution_ids":["https://openalex.org/I4210134778"]},{"raw_affiliation_string":", . - , , of , , ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076046606","display_name":"Nicole Jurkschat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134778","display_name":"BioNTech (Germany)","ror":"https://ror.org/04fbd2g40","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210134778"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nicole Jurkschat","raw_affiliation_strings":["Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany",", . - , , of , , "],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany","institution_ids":["https://openalex.org/I4210134778"]},{"raw_affiliation_string":", . - , , of , , ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068328739","display_name":"Claudia Paulmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134778","display_name":"BioNTech (Germany)","ror":"https://ror.org/04fbd2g40","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210134778"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Claudia Paulmann","raw_affiliation_strings":["Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany",", . - , , of , , "],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany","institution_ids":["https://openalex.org/I4210134778"]},{"raw_affiliation_string":", . - , , of , , ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066972371","display_name":"Sandra Prassl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134778","display_name":"BioNTech (Germany)","ror":"https://ror.org/04fbd2g40","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210134778"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sandra Prassl","raw_affiliation_strings":["Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany",", . - , , of , , "],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany","institution_ids":["https://openalex.org/I4210134778"]},{"raw_affiliation_string":", . - , , of , , ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051184029","display_name":"Linda Veronique Kazandjian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134778","display_name":"BioNTech (Germany)","ror":"https://ror.org/04fbd2g40","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210134778"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Linda V. Kazandjian","raw_affiliation_strings":["Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany",", . - , , of , , "],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biontech SE, Forstenrieder Str. 8-14, 82061 Neuried, Germany","institution_ids":["https://openalex.org/I4210134778"]},{"raw_affiliation_string":", . - , , of , , ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060575051","display_name":"Karin Lor\u00e9","orcid":"https://orcid.org/0000-0001-7679-9494","observed_orcids":["https://orcid.org/0000-0001-7679-9494"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Karin Lor\u00e9","raw_affiliation_strings":["Center of Molecular Medicine, 171 76, Stockholm, Sweden","Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Visionsgatan 4, BioClinicum J7:30, 171 64, Stockholm, Sweden",", . - , , of , , "],"raw_orcid":"https://orcid.org/0000-0001-7679-9494","affiliations":[{"raw_affiliation_string":"Center of Molecular Medicine, 171 76, Stockholm, Sweden","institution_ids":[]},{"raw_affiliation_string":"Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Visionsgatan 4, BioClinicum J7:30, 171 64, Stockholm, Sweden","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]},{"raw_affiliation_string":", . - , , of , , ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086501578","display_name":"Falk Nimmerjahn","orcid":"https://orcid.org/0000-0002-5418-316X","observed_orcids":["https://orcid.org/0000-0002-5418-316X"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Falk Nimmerjahn","raw_affiliation_strings":["Division of Genetics, Department of Biology, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, 91058 Erlangen, Germany","FAU Profile Centre Immunomedicine, 91054 Erlangen, Germany"],"raw_orcid":"https://orcid.org/0000-0002-5418-316X","affiliations":[{"raw_affiliation_string":"Division of Genetics, Department of Biology, Friedrich-Alexander-University Erlangen-N\u00fcrnberg, 91058 Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]},{"raw_affiliation_string":"FAU Profile Centre Immunomedicine, 91054 Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"last","author":{"id":null,"display_name":"Stephan Fischer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Stephan Fischer","raw_affiliation_strings":["Icanomab, Tassilostr. 2, 82398 Polling, Germany",", . - , , of , , "],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Icanomab, Tassilostr. 2, 82398 Polling, Germany","institution_ids":[]},{"raw_affiliation_string":", . - , , of , , ","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5086501578"],"corresponding_institution_ids":["https://openalex.org/I181369854"],"apc_list":{"value":1800,"currency":"CHF","value_usd":2046},"apc_paid":{"value":1800,"currency":"CHF","value_usd":2046},"fwci":0.2378,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.44173314,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"13","issue":"2","first_page":"31","last_page":"31"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6342999935150146,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6342999935150146,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.3513000011444092,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.008200000040233135,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cd40-signaling","display_name":"CD40 signaling","score":0.828000009059906},{"id":"https://openalex.org/keywords/anti-cd40-antibody","display_name":"anti-CD40 antibody","score":0.890999972820282},{"id":"https://openalex.org/keywords/agonistic-antibodies","display_name":"agonistic antibodies","score":0.7409999966621399},{"id":"https://openalex.org/keywords/antigen-presenting-cells","display_name":"antigen-presenting cells","score":0.9539999961853027},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.9760000109672546},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8840000033378601},{"id":"https://openalex.org/keywords/humanized-mouse-model","display_name":"humanized mice","score":0.7540000081062317},{"id":"https://openalex.org/keywords/antibody-toxicity","display_name":"antibody toxicity","score":0.4309999942779541}],"concepts":[{"id":"https://openalex.org/C39347974","wikidata":"https://www.wikidata.org/wiki/Q21135811","display_name":"CD40","level":4,"score":0.799883246421814},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6493914723396301},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5596926808357239},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4904026985168457},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.48617666959762573},{"id":"https://openalex.org/C2779931124","wikidata":"https://www.wikidata.org/wiki/Q417823","display_name":"Fc receptor","level":3,"score":0.47919806838035583},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4624043107032776},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.45030510425567627},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4350966513156891},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40386393666267395},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3681041896343231},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.15275728702545166},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1317005157470703},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07570573687553406}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.3390/antib13020031","doi":"https://doi.org/10.3390/antib13020031","is_oa":true,"landing_page_url":"https://doi.org/10.3390/antib13020031","pdf_url":"https://www.mdpi.com/2073-4468/13/2/31/pdf?version=1713447617","source":{"id":"https://openalex.org/S2739070576","display_name":"Antibodies","issn_l":"2073-4468","issn":["2073-4468"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antibodies","raw_type":"journal-article"},{"id":"doi:10.1101/2023.01.16.521736","doi":"https://doi.org/10.1101/2023.01.16.521736","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2023.01.16.521736","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2023/01/18/2023.01.16.521736.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"doi:10.21203/rs.3.rs-3162858/v1","doi":"https://doi.org/10.21203/rs.3.rs-3162858/v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.21203/rs.3.rs-3162858/v1","pdf_url":"https://www.researchsquare.com/article/rs-3162858/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:11036229","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11036229","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11036229/pdf/antibodies-13-00031.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antibodies (Basel)","raw_type":"Text"},{"id":"pmid:38651411","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38651411","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antibodies (Basel, Switzerland)","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:365c7b3037aa408db99a37f815277aa8","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/365c7b3037aa408db99a37f815277aa8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antibodies, Vol 13, Iss 2, p 31 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3390/antib13020031","doi":"https://doi.org/10.3390/antib13020031","is_oa":true,"landing_page_url":"https://doi.org/10.3390/antib13020031","pdf_url":"https://www.mdpi.com/2073-4468/13/2/31/pdf?version=1713447617","source":{"id":"https://openalex.org/S2739070576","display_name":"Antibodies","issn_l":"2073-4468","issn":["2073-4468"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antibodies","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5027012519","display_name":null,"funder_award_id":"TRR305-B02","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"},{"id":"https://openalex.org/G6496555215","display_name":null,"funder_award_id":"TRR305","funder_id":"https://openalex.org/F4320320879","funder_display_name":"Deutsche Forschungsgemeinschaft"}],"funders":[{"id":"https://openalex.org/F4320320879","display_name":"Deutsche Forschungsgemeinschaft","ror":"https://ror.org/018mejw64"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4394914166.pdf","grobid_xml":"https://content.openalex.org/works/W4394914166.grobid-xml"},"referenced_works_count":68,"referenced_works":["https://openalex.org/W1485526722","https://openalex.org/W1501518736","https://openalex.org/W1594509286","https://openalex.org/W1632142035","https://openalex.org/W1914573154","https://openalex.org/W1969689981","https://openalex.org/W1982861708","https://openalex.org/W1995262656","https://openalex.org/W2004312434","https://openalex.org/W2011984976","https://openalex.org/W2016516934","https://openalex.org/W2017873446","https://openalex.org/W2031993474","https://openalex.org/W2033126819","https://openalex.org/W2035070408","https://openalex.org/W2037084317","https://openalex.org/W2038597656","https://openalex.org/W2054540030","https://openalex.org/W2078009629","https://openalex.org/W2079435298","https://openalex.org/W2082554712","https://openalex.org/W2082703193","https://openalex.org/W2090770261","https://openalex.org/W2095701899","https://openalex.org/W2096158777","https://openalex.org/W2104088439","https://openalex.org/W2112853593","https://openalex.org/W2130819559","https://openalex.org/W2142079449","https://openalex.org/W2146146606","https://openalex.org/W2148838644","https://openalex.org/W2153908836","https://openalex.org/W2169772944","https://openalex.org/W2238845110","https://openalex.org/W2342926381","https://openalex.org/W2404465151","https://openalex.org/W2411733041","https://openalex.org/W2475972645","https://openalex.org/W2559803603","https://openalex.org/W2562450957","https://openalex.org/W2587048937","https://openalex.org/W2598879757","https://openalex.org/W2604278437","https://openalex.org/W2749771768","https://openalex.org/W2782231020","https://openalex.org/W2785376969","https://openalex.org/W2791483720","https://openalex.org/W2796894486","https://openalex.org/W2807087106","https://openalex.org/W2876750881","https://openalex.org/W2888826808","https://openalex.org/W2889643652","https://openalex.org/W2897324861","https://openalex.org/W2899183778","https://openalex.org/W2912548334","https://openalex.org/W3027871570","https://openalex.org/W3163236948","https://openalex.org/W3165190396","https://openalex.org/W3197847933","https://openalex.org/W4284971080","https://openalex.org/W4284971931","https://openalex.org/W4297998355","https://openalex.org/W4308346292","https://openalex.org/W4318820629","https://openalex.org/W4328088997","https://openalex.org/W4366989230","https://openalex.org/W4381839016","https://openalex.org/W4386096600"],"related_works":["https://openalex.org/W4307552612","https://openalex.org/W1982861708","https://openalex.org/W4362596126","https://openalex.org/W4302399354","https://openalex.org/W4403520292","https://openalex.org/W1970907457","https://openalex.org/W2057301643","https://openalex.org/W4391133085","https://openalex.org/W3213388104","https://openalex.org/W4255133931"],"abstract_inverted_index":{"Abstract":[0],"Activation":[1],"of":[2,28,34,49,69,86,116,120,124,137,149,171,184,198,215],"CD40-mediated":[3],"signaling":[4,36,127],"in":[5,23,57,118,130,151],"antigen-presenting":[6,55,172,199],"cells":[7,56,80,173,200],"is":[8],"a":[9,100,155],"promising":[10],"therapeutic":[11,218],"strategy":[12],"to":[13,41,90,98,102],"promote":[14],"immune":[15],"responses":[16],"against":[17],"tumors.":[18],"Agonistic":[19],"anti-CD40":[20,65,112,143,175],"antibodies":[21,51,66,176,208],"currently":[22],"development":[24],"require":[25],"Fc\u03b3-receptor-mediated":[26],"crosslinking":[27],"CD40":[29,35,50,96,126,207],"molecules":[30],"for":[31,191,217],"meaningful":[32],"activation":[33,170],"but":[37],"have":[38],"limitations":[39],"due":[40],"dose-limiting":[42],"toxicities.":[43],"Here":[44],"we":[45],"describe":[46],"the":[47,91,108,121,141,160,182],"identification":[48],"which":[52],"strongly":[53],"stimulate":[54],"an":[58,82,185,210],"entirely":[59],"Fc-independent":[60],"manner.":[61],"These":[62,165],"novel":[63,161,205],"Fc-silenced":[64,162,206],"induce":[67],"upregulation":[68],"costimulatory":[70],"receptors":[71],"CD80":[72],"and":[73,75,180,187,201],"CD86":[74],"cytokine":[76],"release":[77],"by":[78],"dendritic":[79],"with":[81,159,174,204],"efficacy":[83],"exceeding":[84],"that":[85],"existing":[87],"antibodies.":[88],"Binding":[89],"CD40L":[92],"interaction":[93],"region":[94],"on":[95],"appears":[97],"be":[99],"prerequisite":[101],"achieving":[103],"such":[104],"strong":[105],"activities.":[106],"Finally,":[107],"most":[109],"active":[110],"identified":[111],"antibody":[113,144],"shows":[114],"evidence":[115],"activity":[117,179],"terms":[119],"expected":[122],"markers":[123],"canonical":[125,163,212],"when":[128],"injected":[129],"humanized":[131,202],"mice.":[132],"There":[133],"are":[134],"no":[135],"signs":[136,148],"obvious":[138],"toxicities":[139],"whereas":[140],"clinical-stage":[142],"CP-870,893":[145],"induced":[146],"severe":[147],"toxicity":[150],"these":[152],"animals":[153],"despite":[154],"lower":[156],"dose":[157],"compared":[158],"agonist.":[164],"studies":[166],"thus":[167],"demonstrate":[168],"potent":[169],"lacking":[177],"Fc\u03b3-receptor-binding":[178],"open":[181],"possibility":[183],"efficacious":[186],"safe":[188],"combination":[189],"therapy":[190],"cancer":[192],"patients.":[193],"One":[194],"Sentence":[195],"Summary":[196],"Treatment":[197],"mice":[203],"demonstrates":[209],"Fc\u03b3-receptor-independent":[211],"agonistic":[213],"mode":[214],"action":[216],"use.":[219]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-04-19T00:00:00"}